RSS Feed
July 23rd, 2012 
FAKE NEWS for the Zionist agenda Previous Post: Multiple Sclerosis Drug Doesn’t Prevent Onset of Disability, Study Finds nbsp
FDA OKs Kyprolis for Myeloma
Medical News – The FDA has approved the proteasome inhibitor carfilzomib (Kyprolis) for patients with previously treated multiple myeloma. The approval covers patients who have relapsed or refractory myeloma that has not responded to at least two prior regimens, one of which must be bortezomib (Velcade). Accepted into the FDA’s accelerated approval process, carfilzomib received a thumbs-up from the agency 1 month to the day after the Oncologic Drugs Advisory Committee (ODAC) voted 11-0, with one abstention, to recommend approval.
Tags: disease medicine, nature of corporations, pharmaceuticals
Related posts:
Views: 0
Posted in 
Tags: 
